Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Mojca Jensterle, MD, PhD
- Phone Number: 03861 522 35 64
- Email: mojca.jensterlesever@kclj.si
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with congenital heart disease attending regular follow up
Exclusion Criteria:
- missing main data in medical documentation
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Patients with cyanotic Congenital Heart Disease
|
|
Patients with acyanotic Congenital Heart Disease
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma metanephrine level
Time Frame: baseline, one point of time in a cross-sectional study
|
Level of plasma metanephrine
|
baseline, one point of time in a cross-sectional study
|
|
Plasma normetanephrine level
Time Frame: baseline, one point of time in a cross-sectional study
|
Level of plasma normetanephrine
|
baseline, one point of time in a cross-sectional study
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypoxemia
Time Frame: baseline, one point of time in a cross-sectional study
|
Length of hypoxemia presence in years
|
baseline, one point of time in a cross-sectional study
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0000 (Centre for care Science, KI, Norrbacka Eugeniastiftelsen)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.